Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3052% above fair value
$10.57−0.69 (-6.13%)
Close on Nov 20, 2026Market cap $233.65MP/E –Yield –
Amarin gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Amarin's gross profit for the twelve months ending Sep 30, 2026 was $72.11M, down 18.2% year over year. For fiscal 2025 it was $120.87M, up 48.5% from the year before. Over ten years it grew 8.4% a year on average. The highest annual figure on record is $482.62M in fiscal 2020.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.87M | +48.5% |
| FY2024 | Dec 31, 2024 | $81.38M | -50.8% |
| FY2023 | Dec 31, 2023 | $165.54M | -31.7% |
| FY2022 | Dec 31, 2022 | $242.48M | -47.5% |
| FY2021 | Dec 31, 2021 | $461.86M | -4.3% |
| FY2020 | Dec 31, 2020 | $482.62M | +44.6% |
| FY2019 | Dec 31, 2019 | $333.74M | +91.1% |
| FY2018 | Dec 31, 2018 | $174.67M | +28.3% |
| FY2017 | Dec 31, 2017 | $136.15M | +42.2% |
| FY2016 | Dec 31, 2016 | $95.72M | +77.7% |
| FY2015 | Dec 31, 2015 | $53.88M | +59.8% |
| FY2014 | Dec 31, 2014 | $33.72M | +133.5% |
| FY2013 | Dec 31, 2013 | $14.44M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $16.18M | -27.1% |
| Q2 FY2026 | Jun 30, 2026 | $14.99M | -70.2% |
| Q1 FY2026 | Mar 31, 2026 | $17.77M | -29.3% |
| Q4 FY2025 | Dec 31, 2025 | $23.17M | – |
| Q3 FY2025 | Sep 30, 2025 | $22.21M | +36.4% |
| Q2 FY2025 | Jun 30, 2025 | $50.36M | +17.8% |
| Q1 FY2025 | Mar 31, 2025 | $25.13M | -21.2% |
| Q4 FY2024 | Dec 31, 2024 | -$9.57M | -121.2% |
| Q3 FY2024 | Sep 30, 2024 | $16.28M | -45.4% |
| Q2 FY2024 | Jun 30, 2024 | $42.77M | +0.2% |
| Q1 FY2024 | Mar 31, 2024 | $31.90M | -33.4% |
| Q4 FY2023 | Dec 31, 2023 | $45.12M | -29.1% |
| Q3 FY2023 | Sep 30, 2023 | $29.82M | -52.6% |
| Q2 FY2023 | Jun 30, 2023 | $42.67M | -2.2% |
| Q1 FY2023 | Mar 31, 2023 | $47.93M | -33.8% |
| Q4 FY2022 | Dec 31, 2022 | $63.60M | -44.1% |
| Q3 FY2022 | Sep 30, 2022 | $62.86M | -43.8% |
| Q2 FY2022 | Jun 30, 2022 | $43.63M | -64.3% |
| Q1 FY2022 | Mar 31, 2022 | $72.39M | -36.4% |
| Q4 FY2021 | Dec 31, 2021 | $113.86M | -14.1% |
| Q3 FY2021 | Sep 30, 2021 | $111.83M | -9.4% |
| Q2 FY2021 | Jun 30, 2021 | $122.33M | +14.8% |
| Q1 FY2021 | Mar 31, 2021 | $113.84M | -5.3% |
| Q4 FY2020 | Dec 31, 2020 | $132.48M | +17.6% |
| Q3 FY2020 | Sep 30, 2020 | $123.43M | +41.9% |
| Q2 FY2020 | Jun 30, 2020 | $106.52M | +36.5% |
| Q1 FY2020 | Mar 31, 2020 | $120.19M | +114.1% |
| Q4 FY2019 | Dec 31, 2019 | $112.61M | +88.2% |
| Q3 FY2019 | Sep 30, 2019 | $86.96M | +108.1% |
| Q2 FY2019 | Jun 30, 2019 | $78.02M | +96.0% |
| Q1 FY2019 | Mar 31, 2019 | $56.14M | +68.7% |
| Q4 FY2018 | Dec 31, 2018 | $59.82M | +47.9% |
| Q3 FY2018 | Sep 30, 2018 | $41.78M | +17.9% |
| Q2 FY2018 | Jun 30, 2018 | $39.80M | +17.6% |
| Q1 FY2018 | Mar 31, 2018 | $33.27M | +25.8% |
| Q4 FY2017 | Dec 31, 2017 | $40.43M | +41.7% |
| Q3 FY2017 | Sep 30, 2017 | $35.44M | – |
| Q2 FY2017 | Jun 30, 2017 | $33.84M | – |
| Q1 FY2017 | Mar 31, 2017 | $26.44M | – |
| Q4 FY2016 | Dec 31, 2016 | $28.54M | – |
See a number that looks wrong?